Back

Efficacy of catheter ablation in patients with persistent atrial fibrillation on chronic ibrutinib therapy

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 13 Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Nicola Pierucci

Hospital Clinic Barcelona, Barcelona (Spain)

8 More presentations in this session

Presentation thumbnail
Functional substrate mapping characteristics during sinus rhythm predicts critical isthmus of scar related atrial tachycardia
Professor H. Yorgun (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Ablation of hemodynamically unstable ventricular tachycardia guided by ultra-high density pacemapping and PASO correlation map, a multi-center clinical trial
Professor D. Huang (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Peak frequency mapping characteristics in patients with scar-related atypical atrial reentrant tachycardias; findings from a novel automated annotation algorithm to detect near field signals
Professor H. Yorgun (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Activation map of koch triangle: a novel approach to AVNRT ablation using CARTO 3 v7
Doctor E. Chieffo (Crema, IT)
Abstract Slides Video
Presentation thumbnail
Long-term results of cardioneuroablation evaluated by implantable loop recorder
Doctor J. Quintal (Setubal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 13

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Transcatheter ablation versus medical therapy in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials.
thumbnail
Congress Presentation
Catheter ablation vs medical management for atrial fibrillation in patients with heart failure: a systematic review and metanalysis
thumbnail
Congress Presentation
Atrial fibrillation recurrence rates in patients with transthyretin cardiac amyloidosis undergoing pulmonary vein isolation: a comparative retrospective study with propensity score matching

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources